Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - OPERATING EXPENSES
Operating Expenses URGN - UroGen Pharma Ltd.
139 M
LAST VALUE
1.36%
2 YEAR CAGR
12.67%
5 YEAR CAGR
44.96%
10 YEAR CAGR